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INTRODUCTION
The human ether-a-go-go-related gene (hERG) encodes the pore-forming subunit of the rapidly activating delayed rectifier K + channel (I Kr ) (Sanguinetti et al., 1995; Trudeau et al., 1995) , which is important for cardiac repolarization. The significant role of I Kr in cardiac repolarization was unequivocally manifested by identifying inherited mutations in hERG as molecular mechanisms for long QT syndrome type-2 (LQTS2) (Sanguinetti and Tristani-Firouzi, 2006) .
Mutations in hERG can reduce I Kr , delay cardiac repolarization and cause inherited LQTS which can lead to ventricular arrhythmias and sudden cardiac death (Keating and Sanguinetti, 2001 ). In addition, a large number of medications can interfere with I Kr function and cause LQTS, a phenomenon known as drug-induced LQTS. These drugs interfere with hERG channel function by either directly blocking the channel (Roy et al., 1996; Zhang et al., 2001) or disrupting hERG expression in the plasma membrane (Ficker et al., 2004; Kuryshev et al., 2005; Rajamani et al., 2006; Wang et al., 2007; Guo et al., 2007) . We previously demonstrated that probucol, a cholesterol-lowering drug which causes LQTS, reduces cell surface expression levels of I Kr in cardiomyocytes and hERG channels in a stable cell line (Guo et al., 2007) . However, the mechanisms of probucol-induced reduction in hERG plasma-membrane expression remain unknown. In the present study, using electrophysiology, Western blot and immunocytochemistry methods, we demonstrated that probucol reduces hERG membrane expression by promoting mature channel degradation through accelerated Cav1 turnover.
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cultured neonatal rat ventricular myocytes, Cs + -rich solutions were used to isolate I Kr from the other potassium currents (Zhang, 2006) . The pipette solution contained 135 mM CsCl, 10 mM EGTA, 5 mM MgATP, 10 mM HEPES (pH 7.2 with CsOH) and the bath solution contained 135 mM CsCl, 1 mM MgCl 2 , 10 mM glucose, 10 mM HEPES, 0.01 mM nifedipine (pH 7.4 with CsOH). Procedures of whole-cell patch clamp method and Cs + -carried I Kr recording were performed as previously described (Zhang, 2006) . Patch-clamp experiments were performed at room temperature (22 ± 1°C).
Western Blot Analysis
Whole cell lysates from hERG-expressing HEK 293 cells were used for analysis. For hERG detection, proteins were separated on 7.0% SDS polyacrylamide gels and electroblotted overnight at 4°C to polyvinylidene difluoride (PVDF) membrane. The membrane was then blocked using 5% nonfat milk and 0.1% Tween 20 in Tris-buffered saline and immunoblotted for 1 h with a rabbit anti-hERG primary antibody (anti-Kv11.1, Sigma). hERG signals were detected using goat anti-rabbit horseradish peroxidase-conjugated secondary antibody and ECL detection kit (GE Healthcare). For co-immunoprecipitation (Co-IP), the total cell lysate was extracted using protease inhibitor cocktail and PMSF (Sigma). Samples of 0.5 mg of protein were incubated with either anti-hERG (N20) or anti-Cav1 overnight at 4 °C, then precipitated with protein A/G plus-agarose beads for 4 h at 4 °C. The samples were washed 3 times with lysis buffer. The beads were resuspended in 2 sample buffer and boiled to remove agarose beads.
The immunoprecipitates were separated using SDS polyacrylamide gel electrophoresis.
Immunofluorescence microscopy
This article has not been copyedited and formatted. The final version may differ from this version. bovine serum albumin in phosphate buffered saline solution. The hERG and Cav1 were labelled with appropriate primary and fluorescence-conjugated secondary antibodies. Nuclei were stained using Hoechst 33342 (0.2 µg/mL, Sigma). Images were acquired using a Leica TCS SP2 Multi Photon confocal microscope.
Reagents
Probucol, brefeldin A, cycloheximide, digitoxin, glycerol, thapsigargin, anti-Kv11.1 antibody, anti-actin antibody and chemicals for patch clamp experiments were purchased from Sigma.
Probucol was dissolved in ethanol to make a 30 mM stock solution. Digitoxin was dissolved in DMSO (Dimethyl Sulfoxide) to make a 0.1 mM stock solution. Anti-hERG (N20, for Co-IP),
anti-Cav1 and anti-GAPDH antibodies, Protein A/G, Cav1 siRNA, and control siRNA were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Low density lipoprotein (LDL) was isolated from cholesterol fed rabbits (Massaeli et al., 1999) . Human LDL was purchased from Calbiochem (San Diego, CA). Sodium 4-phenylbutyrate was purchased from EMD Biosciences.
Data are expressed as the mean ± S.E. To test for statistical significance between control and test groups, 1-way ANOVA or 2-tailed Student's t test was used. A P value of 0.05 or less was considered significant.
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RESULTS
Low density lipoprotein (LDL) effectively rescues probucol-induced I hERG reduction
We previously demonstrated that probucol reduces hERG expression levels in the plasma membrane in a concentration-dependent manner within clinical relevant concentrations (Guo et al., 2007) . Our data demonstrated that chronic probucol exposure reduces I hERG in hERGexpressing HEK cells with an IC 50 of 10.6 µM and native I Kr in cultured neonatal rat cardiac myocytes with an IC 50 of 20.6 µM (Guo et al., 2007) . To investigate the mechanisms for probucol-induced hERG reduction, we used a concentration of 100 µM to maximize the effect of probucol. As shown in Fig. 1A (Rubenstein and Lyons, 2001) . Glycerol rescues the defective ΔF508 CFTR channel trafficking (Zhang et al., 2003) . As shown in Fig. 1B , neither phenylbutyrate nor glycerol had any effect on probucol-induced I hERG reduction. On the other hand, thapsigargin (5 µM) slightly reversed the probucol-induced I hERG reduction. Thapsigargin is a Sarcoplasmic/Endoplasmic Reticulum Ca 2+ -ATPase (SERCA) inhibitor, which has been shown to rescue the trafficking-defective ΔF508 CFTR mutation (Egan et al., 2002) . SERCA inhibitors such as thapsigargin deplete ER luminal [Ca 2+ ] and are thought to alter Ca 2+ -dependent molecular chaperone activity (Corbett and Michalak, 2000) . Thapsigargin also rescues surface expression of trafficking-defective hERG mutants G601S and F805C (Delisle et al., 2003) .
Since thapsigargin may alter the intracellular Ca 2+ homeostasis, we examined the potential role This article has not been copyedited and formatted. The final version may differ from this version. or decrease in Ca 2+ by adding 5 mM EGTA, a Ca 2+ chelator, to the cell culture medium had no effect on probucol-induced I hERG reduction (Fig. 1B) .
Probucol reduces plasma cholesterol levels by accelerating LDL removal (Naruszewicz et al., 1984) . It also inhibits the ATP-binding cassette transporter 1 (ABCA1)-mediated cellular lipid metabolism in cultured J774 macrophages (Favari et al., 2004) . To examine the role of cholesterol in probucol-disrupted hERG expression, we added LDL (0.3 mg/mL, from cholesterol-fed rabbits), a natural cholesterol carrier (Massaeli et al., 1999) , to the probucolcontaining cell culture medium for 48 h. The addition of LDL almost completely restored I hERG ( Fig. 1A and B) . Although less potent, human LDL also rescued the probucol-reduced I hERG (data not shown). Probucol is a lipophilic compound. To exclude the possibility that LDL rescues the probucol effects on hERG via sequestering probucol in the cell culture medium, we tested the effects of LDL on digitoxin-induced I hERG reduction. Digitoxin also reduces hERG expression levels in the plasma membrane (Wang et al., 2007) and is also lipophilic (Joubert, 1990; Belz et al., 2001) . Incubation of hERG-HEK cells with 100 nM digitoxin for 48 h completely eliminated hERG current. However, LDL (0.3 mg/mL) had no effect on digitoxin-induced I hERG reduction (Fig. 1C) . Thus, LDL rescue is specific to probucol-induced I hERG reduction. To further address whether LDL decreases probucol concentration, we compared probucol concentrations in supernatants isolated via centrifugation from cell culture medium containing probucol and from medium containing probucol plus LDL using C 18 reversed-phase HPLC (high-performance liquid chromatography). We cultured hERG-HEK cells in the medium, medium with probucol (100 µM), or with probucol (100 µM) plus LDL (0.3 mg/mL) for 24 h. We then collected media This article has not been copyedited and formatted. The final version may differ from this version. from each culture condition and isolated supernatants using centrifugation (20,000 × g, 1 h).
Supernatants (100 µl) from each medium were eluted at 1 ml/min with acetonitrile/water (80/20) mixture as the mobile phase in HPLC to detect probucol at a wavelength of A241 nm. Our data showed that probucol concentrations were comparable between samples from probucolcontaining medium and probucol/LDL-containing medium (data not shown). Thus, LDL rescue of probucol-induced I hERG reduction is not via decreasing probucol concentration in the cell culture medium.
To determine whether LDL also rescues probucol-induced I Kr reduction in cardiomyocytes, we performed experiments on cultured neonatal rat ventricular myocytes using symmetric Cs + as charge-carrier for I Kr . Fig. 2 shows a family of Cs + currents obtained from a single cardiomyocyte. From a holding potential of −80 mV, depolarizations in 10-mV increments to voltages between −70 and +70 mV for 1 s were applied to evoke currents. Depolarizing steps to voltages more positive than 0 mV induced outward currents that inactivated in a voltagedependent manner. Upon repolarization to −80 mV, the inward tail currents displayed an initial rising phase, which is described as a "hook", reflecting the rapid recovery of inactivated channels to the open state prior to deactivation, and is unique to I Kr . Cs + is well known to block various types of K + channels (Zhang, 2006) . By analyzing the current gating kinetics, especially inactivation and drug sensitivity of the Cs + current in cardiomyocytes and in hERG-expressing stable HEK cells, we have previously demonstrated that the Cs + -current recorded in cardiac myocytes represents pure I Kr (Zhang, 2006) . Similar to expressed hERG channels, I Kr-Cs in cardiomyocytes was essentially eliminated by the incubation of 100 µM probucol for 48 h. As well, addition of LDL (0.3 mg/mL) effectively prevented probucol-induced I Kr reduction (Fig. 2) .
Probucol reduces hERG expression through a Cav1 dependent mechanism
The effects of probucol on hERG expression were examined using Western blot analysis. Total cell proteins were extracted from hERG-HEK cells cultured with 100 µM probucol as well as from cells cultured with 0.3% ethanol as a vehicle control for 48 h. The hERG protein from control cells displayed two bands with molecular masses of 135-and 155-kDa (Fig. 3) . The 155-kDa band represents the mature, fully glycosylated form of functional hERG channels in the plasma membrane, and the 135-kDa band represents the immature, core-glycosylated form residing in the endoplasmic reticulum (Zhou et al., 1998; Guo et al., 2007; Guo et al., 2009 ).
Inclusion of 100 µM probucol to the culture medium for 48 h eliminated the 155-kDa hERG band (Fig. 3 ). Interestingly, Cav1 expression level was also significantly reduced by probucol treatment. Furthermore, LDL effectively rescued both probucol-reduced 155-kDa hERG and Cav1 expression levels (Fig. 3) .
Physical association and co-localization between hERG and Cav1
To determine interactions between hERG and Cav1, we conducted confocal microscopy experiments to examine the co-localization between hERG and Cav1. hERG-HEK cells were cultured in the absence or presence of 100 μM probucol for 48 h. The cells were fixed and permeabilized. hERG channels were labelled using an anti-hERG antibody that targets the Cterminal region of the hERG protein. The antibody recognizes both mature hERG channels in the plasma membrane as well as immature proteins in the endoplasmic reticulum and Golgi apparatus. Cav1 was labelled using appropriate primary and secondary antibodies. Under control conditions, hERG and Cav1 were both detected on the cell membrane (Fig. 4A) . Exposure of This article has not been copyedited and formatted. The final version may differ from this version. (Fig. 4A ).
The association between hERG and Cav1 proteins was examined using Co-IP analysis. Cell lysates were extracted from hERG-HEK cells. An anti-Cav1 antibody was used to immunoprecipitate Cav1 and its associated proteins, while an anti-hERG antibody was used to immunoprecipitate hERG and its associated proteins. The immunoprecipitated proteins were detected using Western blot analysis with anti-hERG or anti-Cav1 antibodies, respectively. As shown in Fig. 4B and 4C, the hERG band was detected in the anti-Cav1 antibody precipitated proteins, while the Cav1 expression was detected in the anti-hERG antibody precipitated proteins.
These results indicate an interaction between hERG and Cav1.
Cav1 facilitates probucol-induced hERG degradation
To further our understanding of the role of Cav1 in probucol-induced hERG reduction, we overexpressed Cav1 in hERG-HEK cells by transfecting the cells with Cav1 plasmids. Twentyfour hours after transfection, cells were cultured in either control medium or 100 µM probucolcontaining medium for 24 h; hERG expression levels and I hERG were then examined. As shown in Fig. 5 , while overexpression of Cav1 did not significantly affect the 155-kDa hERG expression level in control cells, it enhanced probucol-induced reduction of the 155-kDa hERG expression (Fig. 5A) . Similarly, Cav1 overexpression significantly promoted probucol-induced I hERG reduction (Fig. 5B) . Thus, hERG-HEK cells overexpressing Cav1 were much more sensitive to probucol exposure than control hERG-HEK cells.
This article has not been copyedited and formatted. The final version may differ from this version. The hERG-HEK cells express endogenous Cav1. We knocked down endogenous Cav1 expression with siRNA and examined the effects of probucol on hERG expression. Forty-eight hours after transfecting hERG-HEK cells with either Cav1 siRNA or control siRNA, the cells were passaged and exposed to 100 µM probucol for 48 h, and hERG expression levels and I hERG were examined. Cav1 siRNA transfection reduced the endogenous Cav1 expression and significantly impeded the reduction of the 155-kDa hERG expression induced by probucol (Fig.   6A ). As well, Cav1 siRNA transfection significantly impeded probucol-induced I hERG reduction (Fig. 6B) . After 100 µM probucol-treatment for 48 h, I hERG in cells transfected with Cav1 siRNA was significantly larger than I hERG in cells transfected with control siRNA. Altogether, these data indicate that Cav1 is involved in probucol-induced degradation of mature hERG channels.
Probucol increases the turnover rate of Cav1
Our data so far raised a possibility that probucol destabilizes Cav1 in the plasma membrane and promotes its degradation. Since Cav1 associates with mature hERG channels, the accelerated Cav1 turnover may consequently increase hERG degradation by dragging hERG for internalization, thus decreasing hERG expression in the plasma membrane. We tested this possibility by examining the effects of probucol on Cav1 expression in HEK cells without hERG channels. Probucol treatment significantly reduced Cav1 expression levels. Moreover, this effect was completely rescued by LDL (0.3 mg/mL) treatment (Fig. 7A) . To test the notion that probucol destabilizes Cav1, we examined the effects of probucol on the degradation rate of Cav1 in HEK cells whose protein-synthesis was inhibited by 10 μ g/mL cycloheximide (CHX) treatment. As shown in Fig. 7B CHX alone for the same period (decreased by 46 ± 11%, n = 6, P < 0.01). Thus, probucol promotes Cav1 degradation.
To examine the effects of probucol on degradation of mature hERG channels, we blocked forward trafficking with a Golgi transit inhibitor brefeldin A (BFA) which inhibits protein transport from the ER to the Golgi (Guo et al., 2009 ). The hERG-HEK cells were pretreated with BFA (10 µM) for 1 h and then cultured in the absence or presence of probucol in the continued presence of BFA. BFA blocked the conversion of hERG from its immature 135-kDa form into its mature 155-kDa form (Guo et al., 2009 ). Thus, the decrease in the 155-kDa band in the presence of BFA represents the rate of degradation of the pre-existing mature channels. As can be seen from the Western blot analysis and the normalized 155-kDa band intensity (Fig. 8A) , in control cells with BFA, the 155-kDa band decreased by about half in 6 h. In contrast, in probucol-treated cells, the 155-kDa band decreased by about half in only 3 h (Fig. 8A) . Probucol also concomitantly accelerated the decay of Cav1 expression in these cells (Fig. 8A) . The function of hERG channels was also evaluated by whole-cell patch clamp method. Blockade of forward trafficking by BFA (10 µM) resulted in a time-dependent reduction in I hERG (Guo et al., 2009 ).
As shown in Fig. 8B , under conditions where protein forward trafficking was blocked by BFA, probucol significantly accelerated I hERG reduction.
This article has not been copyedited and formatted. The final version may differ from this version. (Roy et al., 1996; Zhang et al., 2001; Ficker et al., 2004; Kuryshev et al., 2005; Rajamani et al., 2006; Wang et al., 2007; Guo et al., 2007) . Probucol is a cholesterol-lowering drug that causes long QT syndrome and Torsades de Pointes arrhythmia in patients (Hayashi et al., 2004) . We previously demonstrated that probucol reduces the expression levels of the mature form of ERG (I Kr protein)
in cultured cardiomyocytes and of 155-kDa hERG channels stably expressed in HEK 293 cells (Guo et al., 2007) . However, the mechanisms of probucol-reduced hERG expression remain unknown.
Drug-induced reduction in cell-surface hERG density has been attributed to defects in hERG forward trafficking (Ficker et al., 2004) . Blockade of hERG forward trafficking usually leads to an increase in the expression of the 135 kDa immature hERG band as shown in Fig. 8A . Our data show that while probucol decreases the upper (155 kDa) band, it does not concomitantly increase the lower (135 kDa) band (Fig. 3) , suggesting that probucol may not block hERG forward trafficking. On the other hand, we demonstrated that accelerated hERG protein degradation from the cell membrane represents an alternative mechanism for drug-induced reduction of hERG channels. We show that probucol reduces the expression of mature hERG channels through a Cav1 dependent pathway, and such reductions can be rescued by the addition of LDL, a potent cholesterol carrier.
Caveolin and cholesterol are two important components of caveolae, which are specialized lipid This article has not been copyedited and formatted. The final version may differ from this version. rafts, forming 50-100 nm "flask shaped" invaginations of the plasma-membrane of many cell types (Simons and Ikonen, 1997) . Caveolae provide platforms for membrane protein interaction, signalling, trafficking and degradation (Brown and London, 1998; Simons and Toomre, 2000; Helms and Zurzolo, 2004) . Caveolin is a cholesterol binding integral membrane protein essential for the formation of caveolae (Rothberg et al., 1992; Murata et al., 1995; Drab et al., 2001 ), Due to its close association with cholesterol, the expression level of caveolin is up-regulated in response to increased levels of cellular cholesterol (Fielding et al., 1997; Hailstones et al., 1998) and down-regulated in response to cholesterol-depletion (Hailstones et al., 1998; Thorn et al., 2003) .
Probucol inhibits cholesterol synthesis in cells and affects cell membrane lipid composition (Favari et al., 2004) . Our data suggest that, by disrupting cholesterol level, probucol destabilizes Cav1 membrane expression and accelerates Cav1 turnover. Due to the physical association between mature hERG and Cav1 (Fig. 4) , accelerated turnover of Cav1 may essentially drag in hERG for degradation, leading to an accelerated degradation rate and a decreased expression level of hERG in the plasma membrane. This notion is directly supported by our data; probucol accelerates Cav1 degradation ( Fig. 7 B and C) ; LDL, a cholesterol carrier, effectively prevented probucol-induced reduction of Cav1 in HEK cells (Fig. 7A) . LDL also prevented probucolinduced reduction of Cav1 and 155-kDa hERG in hERG-HEK cells (Fig. 3) . Overexpression of Cav1 accelerated the probucol-induced hERG reductions (Fig. 5) , while knockdown of Cav1 impeded the probucol effects (Fig. 6) . As well, when protein forward trafficking was blocked, probucol accelerated degradation of both Cav1 and 155-kDa hERG in hERG-HEK cells (Fig.   8A ).
This article has not been copyedited and formatted. The final version may differ from this version. Due to the difficulties in culturing cardiomyocytes where caveolin-3 (Cav3) is innately expressed, we did not examine the time-dependent effects of probucol on the expression levels of Cav3 and rat Ether-a-go-go-Related Gene (rERG)-encoded protein (the I Kr channel) in cardiomyocytes.
However, we previously demonstrated that probucol reduces the 155-kDa band of rERG protein in cultured neonatal rat cardiomyocytes (Guo et al., 2007) . Cav3 is the structurally related muscle-specific caveolin gene family member whose role in striated muscle cells is largely analogous to that of Cav1 in non-muscle cells (Rybin et al., 2003) . We have previously demonstrated that Cav3 associates with the 155 kDa form of I Kr (Massaeli et al., 2010) . We showed that exposure of hERG-HEK cells to 0 mM K + medium triggers rapid internalization of membrane hERG channels and that Cav1 is involved in this process in a stable hERG cell line and Cav3 is involved in the process in cultured neonatal rat ventricular myocytes (Massaeli et al., 2010) .
In summary, our data demonstrated that probucol promoted Cav1 turnover rate which accelerates hERG degradation, leading to a decreased hERG expression level in the plasma membrane.
Furthermore, increasing cholesterol contents by addition of LDL can efficiently impede the probucol effects. Our data provide evidence that by altering the membrane stability and turnover of hERG-interacting protein Cav1, probucol reduces hERG membrane expression, which represents a new mechanism for drugs to disrupt hERG channel function.
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